Research Article
Investigating the Pretreatment miRNA Expression Patterns of Advanced Hepatocellular Carcinoma Patients in Association with Response to TACE Treatment
Table 2
Clinicopathological characteristics of 15 patients with advanced HCC treated with TACE.
| | Patient ID | Age | HCV/cirrhosis | Presentation |
AFP (ng/mL) | Grade | TNM stage | Child-Pugh class | OKUDA stage | CLIP | Response score |
| | Responders | | P1 | 49.00 | +/+ | Jaundice | 16.00 | 2.00 | T1 | B | 2 | 3 | 1.00 | | P2 | 42.00 | ND | Pain | 3.00 | 2.00 | T1 | B | ND | 1 | 1.00 | | P3 | 52.00 | ND | Pain | 969.00 | ND | T3b | B | 2 | 4 | 1.00 | | P4 | 52.00 | +/− | ND |
107000 | 3.00 | T1 | B | 2 | 4 | 2.00 | | P5 | 50.00 | −/+ | ND | 342.00 | 3.00 | T1 | B | ND | 1 | 2.00 |
| | Nonresponders | | P6 | 43.00 | ND | Pain | 276.00 | 2.00 | T2 | ND | 2 | 1 | 4.00 | | P7 | 57.00 | −/+ | ND | 4.00 | 2.00 | T1 | B | 1 | 1 | 3.00 | | P8 | 59.00 | −/+ | Pain | ND | 2.00 | T2 | A | 2 | 2 | 4.00 | | P9 | 57.00 | −/+ | ND | 28.00 | ND | T2 | B | 2 | 2 | 3.00 | | P10 | 52.00 | ND | Pain | 90.00 | 1.00 | T3a | B | 2 | 3 | 4.00 | | P11 | 61.00 | ND | Ascites | 350.00 | 2.00 | T2 | B | 2 | 2 | 5.00 | | P12 | 58.00 | −/+ | ND | 2580.00 | ND | T3a | B | 2 | 4 | 5.00 | | P13 | 67.00 | ND | Recurrence | 978.00 | 2.00 | T3a | A | 2 | 3 | 3.00 | | P14 | 56.00 | +/+ | ND | ND | 2.00 | T1 | A | 1 | 0 | 3.00 | | P15 | 58.00 | −/+ | Pain | 10.00 | 2.00 | T2 | B | 2 | 3 | 4.00 |
|
|
TNM: tumor, node, and metastases; AFP: alpha-fetoprotein; ND: not defined; CLIP: Cancer of the Liver Italian Program.
|
